Visa has announced the launch of a new stablecoin advisory practice aimed at helping banks and businesses navigate the world of digital currencies. This initiative positions the payments giant as a key player in bridging traditional finance with blockchain technology, offering expert guidance on stablecoin implementation, compliance, and integration.Visa has announced the launch of a new stablecoin advisory practice aimed at helping banks and businesses navigate the world of digital currencies. This initiative positions the payments giant as a key player in bridging traditional finance with blockchain technology, offering expert guidance on stablecoin implementation, compliance, and integration.

Visa Launches Stablecoin Advisory Practice for Banks and Businesses

2025/12/18 17:21
2 min read
For feedback or concerns regarding this content, please contact us at crypto.news@mexc.com
News Brief
Visa has announced the launch of a new stablecoin advisory practice aimed at helping banks and businesses navigate the world of digital currencies. This initiative positions the payments giant as a key player in bridging traditional finance with blockchain technology, offering expert guidance on stablecoin implementation, compliance, and integration.

Keywords: Visa stablecoin advisory, stablecoin services for banks, Visa crypto integration, blockchain advisory Visa, digital asset consulting

Visa has announced the launch of a new stablecoin advisory practice aimed at helping banks and businesses navigate the world of digital currencies. This initiative positions the payments giant as a key player in bridging traditional finance with blockchain technology, offering expert guidance on stablecoin implementation, compliance, and integration.

Visa's New Stablecoin Advisory Initiative
In a press release on its official website (Visa Newsroom), Visa revealed the advisory practice will provide tailored consulting services to financial institutions and enterprises interested in stablecoins. Stablecoins, like USDC and USDT, are cryptocurrencies pegged to fiat currencies, offering stability for transactions, remittances, and DeFi applications. The practice will cover areas such as regulatory compliance, risk management, and technical integration with existing payment systems.

This move comes amid growing institutional interest in stablecoins, with global transaction volumes exceeding $10 trillion annually, according to Chainalysis reports (Chainalysis Stablecoin Report). Visa's head of crypto, Cuy Sheffield, emphasized that the advisory will help clients "unlock the potential of stablecoins while ensuring security and compliance."

Why Visa is Entering Stablecoin Advisory
Visa's expansion into advisory services builds on its existing crypto efforts, including partnerships with Circle for USDC and pilots for blockchain settlements. By offering expertise, Visa aims to capitalize on the stablecoin market's projected growth to $2.8 trillion by 2028, per Bernstein Research (Bernstein Stablecoin Forecast). For banks, this means easier entry into digital assets without building infrastructure from scratch, while businesses can explore faster, cheaper cross-border payments.

The initiative aligns with regulatory trends, such as the EU's MiCA framework and US discussions on stablecoin legislation, making advisory crucial for compliance (CoinDesk Regulatory Updates).

Implications for Crypto and Traditional Finance
This launch could accelerate stablecoin adoption, fostering innovation in payments and reducing reliance on traditional banking rails. For crypto users, it signals mainstream validation, potentially boosting liquidity and trust. However, challenges like regulatory scrutiny and volatility remain.

Industry experts view it positively: "Visa's advisory practice democratizes stablecoin access, bridging TradFi and DeFi," noted analyst Sarah Tran from Messari (Messari Stablecoin Analysis).

Outlook and Future Developments
As Visa rolls out this practice, expect collaborations with major banks and fintechs. This could pave the way for more tokenized assets and seamless crypto-fiat conversions. For the latest on stablecoin services for banks and Visa crypto integration, monitor updates from reliable sources like Reuters Crypto News.

Disclaimer: The articles published on this page are written by independent contributors and do not necessarily reflect the official views of MEXC. All content is intended for informational and educational purposes only and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC. Cryptocurrency markets are highly volatile — please conduct your own research and consult a licensed financial advisor before making any investment decisions.

You May Also Like

Vitalik Buterin to Ethereum Developers: Build It Like It Has to Last Without You

Vitalik Buterin to Ethereum Developers: Build It Like It Has to Last Without You

Key Takeaways Vitalik Buterin wants Ethereum apps built to survive without developers, corporate servers, or trusted third parties Two major […] The post Vitalik
Share
Coindoo2026/03/07 15:49
Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

The post Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution appeared on BitcoinEthereumNews.com. In this week’s edition of InnovationRx, we look at possible pain treatments from cannabis, risks of new vaccine restrictions, virtual clinical trials at the Mayo Clinic, GSK’s $30 billion U.S. manufacturing commitment, and more. To get it in your inbox, subscribe here. Despite their addictive nature, opioids continue to be a major treatment for pain due to a lack of effective alternatives. In an effort to boost new drugs, the FDA released new guidelines for non-opioid painkillers last week. But making these drugs hasn’t been easy. Vertex Pharmaceuticals received FDA approval for its non-opioid Journavx in January, then abandoned a next generation drug after a failed clinical trial earlier this summer. Acadia similarly abandoned a promising candidate after a failed trial in 2022. One possible basis for non-opioids might be cannabis. Earlier this year, researchers at Washington University at St. Louis and Stanford published a study showing that a cannabis-derived compound successfully eased pain in mice with minimal side effects. Munich-based pharmaceutical company Vertanical is perhaps the furthest along in this quest. It is developing a cannabinoid-based extract to treat chronic pain it hopes will soon become an approved medicine, first in the European Union and eventually in the United States. The drug, currently called Ver-01, packs enough low levels of cannabinoids (including THC) to relieve pain, but not so much that patients get high. Founder Clemens Fischer, a 50-year-old medical doctor and serial pharmaceutical and supplement entrepreneur, hopes it will become the first cannabis-based painkiller prescribed by physicians and covered by insurance. Fischer founded Vertanical, with his business partner Madlena Hohlefelder, in 2017, and has invested more than $250 million of his own money in it. With a cannabis cultivation site and drug manufacturing plant in Denmark, Vertanical has successfully passed phase III clinical trials in Germany and expects…
Share
BitcoinEthereumNews2025/09/18 05:26
Short-term profit-taking pushes Bitcoin back below key $70K level – What next?

Short-term profit-taking pushes Bitcoin back below key $70K level – What next?

The post Short-term profit-taking pushes Bitcoin back below key $70K level – What next? appeared on BitcoinEthereumNews.com. Bitcoin [BTC] rallied as high as $74
Share
BitcoinEthereumNews2026/03/07 16:09